Efficacy of Ustekinumab for the treatment of perianal fistulizing Crohn’s disease: a multicentre retrospective study - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Effectiveness of Ustekinumab in Managing Perianal Fistulizing Crohn's Disease: A Multicenter Retrospective Analysis

  • By

  • Youran Li

  • Xiaomei Sun

  • Ke Wen

  • Lu Lu

  • Wei Wang

  • Minna Wu

  • Jiaze Ma

  • Zailong Zhou

  • Yunfei Gu

  • July 10, 2026

Share

Original Source(s)

Efficacy of Ustekinumab for the treatment of perianal fistulizing Crohn’s disease: a multicentre retrospective study

  • by Youran Li, Xiaomei Sun, Ke Wen, Lu Lu, Wei Wang, Minna Wu, Jiaze Ma, Zailong Zhou, Yunfei Gu

  • July 10, 2026

Related Content

TNFAIP3/A20 dysfunction drives innate and sterile hyperinflammation

Association between OLD and IBD: a systematic review and meta-analysis

Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease